Advertisement

Drugs & Aging

, Volume 35, Issue 1, pp 83–91 | Cite as

Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care

  • Stephanie L. Harrison
  • Lisa Kouladjian O’Donnell
  • Clare E. Bradley
  • Rachel Milte
  • Suzanne M. Dyer
  • Emmanuel S. Gnanamanickam
  • Enwu Liu
  • Sarah N. Hilmer
  • Maria Crotty
Original Research Article

Abstract

Background

Inappropriate polypharmacy may negatively impact the quality of life of residents in aged care facilities, but it remains unclear which medications may influence this reduced quality of life.

Objective

The objective of this study was to examine whether the Drug Burden Index and potentially inappropriate medications were associated with quality of life in older adults living in residential care with a high prevalence of cognitive impairment and dementia.

Methods

We conducted cross-sectional analyses of 541 individuals recruited from 17 residential aged care facilities in Australia in the Investigating Services Provided in the Residential Environment for Dementia (INSPIRED) study. Quality of life was measured using the EuroQol Five Dimensions Questionnaire (a measure of generic quality of life) and the Dementia Quality of Life Questionnaire completed by the participant or a proxy.

Results

In the 100 days prior to recruitment, 83.1% of the participants received at least one anticholinergic or sedative medication included in the Drug Burden Index and 73.0% received at least one potentially inappropriate medication according to the Beers Criteria. Multi-level linear models showed there was a significant association between a higher Drug Burden Index and lower quality of life according to the EuroQol Five Dimensions Questionnaire [β (standard error): − 0.034 (0.012), p = 0.006] after adjustment for potential confounding factors. Increasing numbers of potentially inappropriate medications were also associated with lower EuroQol Five Dimensions Questionnaire scores [− 0.030 (0.010), p = 0.003] and Dementia Quality of Life Questionnaire-Self-Report-Utility scores [− 0.020 (0.009), p = 0.029]. Exposure to both Drug Burden Index-associated medications and potentially inappropriate medications was associated with lower Dementia Quality of Life Questionnaire-Self-Report-Utility scores [− 0.034 (0.017), p = 0.049].

Conclusion

Exposure to anticholinergic and sedative medications and potentially inappropriate medications occurred in over three-quarters of a population of older adults in residential care and was associated with a lower quality of life.

Notes

Acknowledgements

The authors sincerely thank the INSPIRED study participants and their family members for their participation and interest in the study. The assistance of facility staff, care worker researchers, facility pharmacists and data collectors in each state is gratefully acknowledged. We thank members of the study team Mrs Anne Whitehouse, Mrs Angela Basso, Ms Keren McKenna, Dr. Wendy Shulver and Dr. Rebecca Bilton for their input into the INSPIRED study management, data collection and data coordination.

Funding

This study and the researchers are supported by funding provided by the National Health and Medical Research Council Cognitive Decline Partnership Centre (Grant no. GNT9100000). This Partnership Centre includes Australian aged care residential service providers: HammondCare, Helping Hand Aged Care and Brightwater Care Group. Although these industry partners did not provide funding for this study they did provide advice and access to their facilities. The contents of the published materials are solely the responsibility of the administering institution, Flinders University and the individual authors identified, and do not reflect the views of the National Health and Medical Research Council or any other funding bodies or the funding partners. No sources of funding other than that described above (Grant no. GNT9100000) were used to assist in the conduct of this study or preparation of this article.

Compliance with Ethical Standards

Conflict of interest

Suzanne Dyer was employed in the development of the Clinical Practice Guidelines for Dementia in Australia, which includes recommendations relating to the use of pharmaceuticals in dementia. Stephanie Harrison, Lisa Kouladjian O’Donnell, Clare Bradley, Rachel Milte, Emmanuel Gnanamanickam, Enwu Liu, Sarah Hilmer and Maria Crotty have no conflicts of interest directly relevant to the content of this article.

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee (Flinders Social and Behavioural Research Ethics Committee: Approval Nos. 6732 and 6753). Informed consent was obtained from all individual participants included in the study (self-consent or proxy) as approved by the ethics committee.

Supplementary material

40266_2017_513_MOESM1_ESM.docx (20 kb)
Supplementary material 1 (DOCX 19 kb)

References

  1. 1.
    Lee DTF, Yu DSF, Kwong ANL. Quality of life of older people in residential care home: a literature review. J Nurs Healthc Chronic Illn. 2009;1(2):116–25.  https://doi.org/10.1111/j.1752-9824.2009.01018.x.CrossRefGoogle Scholar
  2. 2.
    Franic DM, Jiang JZ. Potentially inappropriate drug use and health-related quality of life in the elderly. Pharmacotherapy. 2006;26(6):768–78.  https://doi.org/10.1592/phco.26.6.768.CrossRefPubMedGoogle Scholar
  3. 3.
    Department of Health and Ageing. Evaluation of the impact of accreditation on the delivery of quality of care and quality of life to residents in Australian Government subsidised residential aged care homes. 2007. http://apo.org.au/node/8564. [Accessed 15 Dec 2017].
  4. 4.
    Borowiak E, Kostka T. Predictors of quality of life in older people living at home and in institutions. Aging Clin Exp Res. 2004;16(3):212–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Banerjee S, Samsi K, Petrie CD, Alvir J, Treglia M, Schwam EM, et al. What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia. Int J Geriatr Psychiatry. 2009;24(1):15–24.  https://doi.org/10.1002/gps.2090.CrossRefPubMedGoogle Scholar
  6. 6.
    AIHW. Residential aged care and home care 2013–14. 2014. http://www.aihw.gov.au/aged-care/residential-and-home-care-2013-14/. [Accessed 15 Dec 2017].
  7. 7.
    American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.  https://doi.org/10.1111/jgs.13702.CrossRefGoogle Scholar
  8. 8.
    Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165(1):68–74.  https://doi.org/10.1001/archinte.165.1.68.CrossRefPubMedGoogle Scholar
  9. 9.
    Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN. Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. 2012;52(2):258–65.  https://doi.org/10.1177/0091270010395591.CrossRefPubMedGoogle Scholar
  10. 10.
    Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–7.  https://doi.org/10.1001/archinte.167.8.781.CrossRefPubMedGoogle Scholar
  11. 11.
    Kouladjian L, Gnjidic D, Chen TF, Mangoni AA, Hilmer SN. Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9:1503–15.  https://doi.org/10.2147/CIA.S66660.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies. Eur J Clin Pharmacol. 2017;73(3):257–66.  https://doi.org/10.1007/s00228-016-2162-6.CrossRefPubMedGoogle Scholar
  13. 13.
    Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753–8.  https://doi.org/10.1002/pds.3624.CrossRefPubMedGoogle Scholar
  14. 14.
    Wilson NM, Hilmer SN, March LM, Chen JS, Gnjidic D, Mason RS, et al. Associations between drug burden index and mortality in older people in residential aged care facilities. Drugs Aging. 2012;29(2):157–65.  https://doi.org/10.2165/11598570-000000000-00000.CrossRefPubMedGoogle Scholar
  15. 15.
    Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et al. Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing. 2010;39(4):503–7.  https://doi.org/10.1093/ageing/afq053.CrossRefPubMedGoogle Scholar
  16. 16.
    Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.  https://doi.org/10.1007/s11136-011-9903-x.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, et al. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation. Health Technol Assess. 2013;17(5):v–xv–1–140.  https://doi.org/10.3310/hta17050.CrossRefGoogle Scholar
  18. 18.
    Devlin N, Shah KK, Feng Y, Mulhern B, Van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. HEDS Discussion Paper Series (1602). Sheffield: University of Sheffield: Health Economics and Decision Science, School of Health and Related Research (ScHARR); 2016.Google Scholar
  19. 19.
    Cohen-Mansfield J, Marx MS, Regier NG, Dakheel-Ali M. The impact of personal characteristics on engagement in nursing home residents with dementia. Int J Geriatr Psychiatry. 2009;24(7):755–63.  https://doi.org/10.1002/gps.2192.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Palm R, Kohler K, Schwab CG, Bartholomeyczik S, Holle B. Longitudinal evaluation of dementia care in German nursing homes: the “DemenzMonitor” study protocol. BMC Geriatr. 2013;13:123.  https://doi.org/10.1186/1471-2318-13-123.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Bosboom PR, Alfonso H, Almeida OP, Beer C. Use of potentially harmful medications and health-related quality of life among people with dementia living in residential aged care facilities. Dement Geriatr Cogn Dis Extra. 2012;2(1):361–71.  https://doi.org/10.1159/000342172.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kaplan RM. The minimally clinically important difference in generic utility-based measures. COPD. 2005;2(1):91–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Chen P, Lin KC, Liing RJ, Wu CY, Chen CL, Chang KC. Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation. Qual Life Res. 2016;25(6):1585–96.  https://doi.org/10.1007/s11136-015-1196-z.CrossRefPubMedGoogle Scholar
  24. 24.
    Oremus M, Tarride JE, Clayton N, Raina P, Canadian Willingness-to-Pay Study Group. Health utility scores in Alzheimer’s disease: differences based on calculation with American and Canadian preference weights. Value Health. 2014;17(1):77–83.  https://doi.org/10.1016/j.jval.2013.10.009.CrossRefPubMedGoogle Scholar
  25. 25.
    Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging. 2008;25(9):777–93.CrossRefPubMedGoogle Scholar
  26. 26.
    Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.  https://doi.org/10.1001/jamainternmed.2015.0324.CrossRefPubMedGoogle Scholar
  27. 27.
    Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.  https://doi.org/10.1111/bcp.12732.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Garcia-Gollarte F, Baleriola-Julvez J, Ferrero-Lopez I, Cuenllas-Diaz A, Cruz-Jentoft AJ. An educational intervention on drug use in nursing homes improves health outcomes resource utilization and reduces inappropriate drug prescription. J Am Med Dir Assoc. 2014;15(12):885–91.  https://doi.org/10.1016/j.jamda.2014.04.010.CrossRefPubMedGoogle Scholar
  29. 29.
    Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–54.  https://doi.org/10.1038/clpt.2011.44.CrossRefPubMedGoogle Scholar
  30. 30.
    Dalleur O, Boland B, Losseau C, Henrard S, Wouters D, Speybroeck N, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291–8.  https://doi.org/10.1007/s40266-014-0157-5.CrossRefPubMedGoogle Scholar
  31. 31.
    Pitkala KH, Juola AL, Kautiainen H, Soini H, Finne-Soveri UH, Bell JS, et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. J Am Med Dir Assoc. 2014;15(12):892–8.  https://doi.org/10.1016/j.jamda.2014.04.002.CrossRefPubMedGoogle Scholar
  32. 32.
    Potter K, Flicker L, Page A, Etherton-Beer C. Deprescribing in frail older people: a randomised controlled trial. PLoS One. 2016;11(3):e0149984.  https://doi.org/10.1371/journal.pone.0149984.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res. 2004;4(1):6.  https://doi.org/10.1186/1472-6963-4-6.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Price SD, Holman CD, Sanfilippo FM, Emery JD. Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother. 2014;48(1):6–16.  https://doi.org/10.1177/1060028013504904.CrossRefPubMedGoogle Scholar
  35. 35.
    Skoldunger A, Fastbom J, Wimo A, Fratiglioni L, Johnell K. Impact of inappropriate drug use on hospitalizations, mortality, and costs in older persons and persons with dementia: findings from the SNAC study. Drugs Aging. 2015;32(8):671–8.  https://doi.org/10.1007/s40266-015-0287-4.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Diaz-Redondo A, Rodriguez-Blazquez C, Ayala A, Martinez-Martin P, Forjaz MJ, Spanish Research Group on Quality of Life. EQ-5D rated by proxy in institutionalized older adults with dementia: psychometric pros and cons. Geriatr Gerontol Int. 2014;14(2):346–53.  https://doi.org/10.1111/ggi.12108.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Stephanie L. Harrison
    • 1
    • 2
  • Lisa Kouladjian O’Donnell
    • 2
    • 3
  • Clare E. Bradley
    • 1
    • 2
    • 4
  • Rachel Milte
    • 1
    • 2
    • 5
  • Suzanne M. Dyer
    • 1
    • 2
  • Emmanuel S. Gnanamanickam
    • 1
    • 2
  • Enwu Liu
    • 1
    • 2
    • 6
  • Sarah N. Hilmer
    • 2
    • 3
  • Maria Crotty
    • 1
    • 2
  1. 1.Department of Rehabilitation, Aged and Extended Care, Faculty of Medicine, Nursing and Health Sciences, School of Health SciencesFlinders University, Level 4, Rehabilitation building, Flinders Medical CentreBedford ParkAustralia
  2. 2.NHMRC Cognitive Decline Partnership CentreUniversity of SydneySydneyAustralia
  3. 3.Kolling Institute of Medical Research, University of Sydney and Royal North Shore HospitalSt LeonardsAustralia
  4. 4.Infection and Immunity—Aboriginal Health, SAHMRIAdelaideAustralia
  5. 5.Institute for ChoiceUniversity of South AustraliaAdelaideAustralia
  6. 6.Mary MacKillop Institute for Health ResearchAustralian Catholic UniversityMelbourneAustralia

Personalised recommendations